HAS1 and lung cancer: In a rat model of orthotopic lung cancer, intranasal administration of liposomal triptolide significantly inhibited lung tumor growth and these effects were paralleled by reduced tumor cell proliferation, and lower HAS, HA and CD44/RHAMM levels in the tumor tissues.